
Cerezyme (imiglucerase) Injection Shortage
Please see the following information about the current Cerezyme supply shortage as well as information about alternate therapies for Gaucher patients.
Dear Doctor letter
http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM176861.pdf
Dear Patient letter
http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM176864.pdf
Request Form
http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM176875.pdf
Genzyme Corporation contact information: Genzyme Medical Information: medinfo@genzyme.com or 1-800-745-4447, option 2
Please see the web sites listed below for additional information:
Genzyme supply update
http://supplyupdate.genzyme.com/
Treatment Protocol of Velaglucerase Alfa
http://www.clinicaltrials.gov/ct2/show/NCT00954460?term=velaglucerase&rank
Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
http://www.clinicaltrials.gov/ct2/show/NCT00962260?term=prgcd
No hay comentarios:
Publicar un comentario